Detalles de la búsqueda
1.
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
BMC Infect Dis
; 23(1): 118, 2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36829111
2.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Vaccine X
; 15: 100401, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941802
Resultados
1 -
2
de 2
1
Próxima >
>>